Continuation of my analysis. As a fundamental background, I continue to expect the number of unfortunate Chinese coronavirus infections to continue to rise. This can further increase panic. Further raising the stakes in some of the pharmaceutical companies directly (NVAX) or indirectly (BPMX) in the biotechnology sector.
nCOV is highly spreadable but with low fatality. Therefore ultimately I project increasing numbers of cases and deaths. (This does not mean I wish to see these sorts of things).
There is also a probability that nCOV is likely to mutate, become more difficult to treat or manage - and therefore likely to become a chronic epidemic.